GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Boundless Bio Inc (NAS:BOLD) » Definitions » Quick Ratio

BOLD (Boundless Bio) Quick Ratio : 20.45 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Boundless Bio Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Boundless Bio's quick ratio for the quarter that ended in Jun. 2024 was 20.45.

Boundless Bio has a quick ratio of 20.45. It generally indicates good short-term financial strength.

The historical rank and industry rank for Boundless Bio's Quick Ratio or its related term are showing as below:

BOLD' s Quick Ratio Range Over the Past 10 Years
Min: 8.8   Med: 13.27   Max: 20.45
Current: 20.45

During the past 3 years, Boundless Bio's highest Quick Ratio was 20.45. The lowest was 8.80. And the median was 13.27.

BOLD's Quick Ratio is ranked better than
93.1% of 1508 companies
in the Biotechnology industry
Industry Median: 3.52 vs BOLD: 20.45

Boundless Bio Quick Ratio Historical Data

The historical data trend for Boundless Bio's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boundless Bio Quick Ratio Chart

Boundless Bio Annual Data
Trend Dec21 Dec22 Dec23
Quick Ratio
19.28 8.80 13.27

Boundless Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.90 13.09 13.27 10.54 20.45

Competitive Comparison of Boundless Bio's Quick Ratio

For the Biotechnology subindustry, Boundless Bio's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boundless Bio's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Boundless Bio's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Boundless Bio's Quick Ratio falls into.



Boundless Bio Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Boundless Bio's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(124.204-0)/9.359
=13.27

Boundless Bio's Quick Ratio for the quarter that ended in Jun. 2024 is calculated as

Quick Ratio (Q: Jun. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(183.132-0)/8.957
=20.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boundless Bio  (NAS:BOLD) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Boundless Bio Quick Ratio Related Terms

Thank you for viewing the detailed overview of Boundless Bio's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Boundless Bio Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
9880 Campus Point Drive, Suite 120, San Diego, CA, USA, 92121
Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.